- Previous Close
9.04 - Open
9.00 - Bid 8.92 x --
- Ask 8.93 x --
- Day's Range
8.87 - 9.09 - 52 Week Range
5.76 - 11.27 - Volume
7,019,597 - Avg. Volume
8,307,550 - Market Cap (intraday)
7.415B - Beta (5Y Monthly) -0.03
- PE Ratio (TTM)
22.90 - EPS (TTM)
0.39 - Earnings Date --
- Forward Dividend & Yield 0.13 (1.43%)
- Ex-Dividend Date Jul 12, 2024
- 1y Target Est
--
Zhejiang Ausun Pharmaceutical Co., Ltd. engages in the research and development, process development, manufacture, and sale of APIs and pharmaceutical intermediates. It offers fluorine products, prostaglandins, antimicrobials, and oncology products. The company also provides products for liver disease, respiratory system, and cardiac and cerebral vessels, as well as CNS indications. In addition, it offers development and manufacturing services to the pharmaceutical, cosmetics, and nutritional industries. The company was founded in 2010 and is based in Linhai, China.
www.ausunpharm.comRecent News: 603229.SS
View MorePerformance Overview: 603229.SS
Trailing total returns as of 10/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 603229.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 603229.SS
View MoreValuation Measures
Market Cap
7.51B
Enterprise Value
6.72B
Trailing P/E
23.09
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.94
Price/Book (mrq)
3.23
Enterprise Value/Revenue
8.00
Enterprise Value/EBITDA
19.48
Financial Highlights
Profitability and Income Statement
Profit Margin
32.55%
Return on Assets (ttm)
5.85%
Return on Equity (ttm)
12.39%
Revenue (ttm)
840.44M
Net Income Avi to Common (ttm)
273.54M
Diluted EPS (ttm)
0.39
Balance Sheet and Cash Flow
Total Cash (mrq)
989.38M
Total Debt/Equity (mrq)
8.75%
Levered Free Cash Flow (ttm)
-228.61M